Wheeler Bio: $14m in seed funding
Biomanufacturing company Wheeler Bio has announced the closing of a $14m USD seed financing round. The funding reportedly will be used to expand its staff and make its Portable CMC solution more widely available.
“We are delighted to have the continued support of partners and investors as we work to solve the biggest problems associated with tech transfer,” said Jesse McCool, CEO and co-founder of Wheeler Bio. “With Portable CMC, we can empower preclinical CROs to halve the time to clinical supply for their customers, while significantly de-risking program onboarding for our CDMO partners; this means more medicines reach more patients faster.”
